Krebs Biochemicals and Industries Ltd

KREB.IN

$0.86

Closing

▼-0.90%

1D

▼-8.68%

YTD

Market cap

$18.52M

52 week high

$1.13

52 week low

$0.71

Volume

1,445

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$18.52M

Analysts' Rating

-

Price Target (Mean)

Unable to collect data for some field(s).

Total Analysts

0

P/E

Operating Margin

-17.54%

Beta

0.99

Revenue Growth (Annual)

-18.96%

52 week high

$1.13

52 week low

$0.71

Div. Yield

%

EPS Annual Growth

0.00

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients. The Company develops commercially viable biotech processes for application in medicine, agriculture and industry. It is also engaged in chemical synthesis, fermentation and enzymatic technologies. It manufactures various products, such as Androstenedione for use as steroid intermediate, and Lovastatin and Simvastatin for anti-cholesterol. It also undertakes contract manufacturing for pharmaceutical and multinational companies and developing products for sale in global markets. It has also products in the pilot or research and development stages, which include Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan and Phenylephrine. It has two manufacturing facilities, one is located at Regadichelaka, Nellore District, and another one located at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.